POST Online Media Lite Edition



 

10,000 volunteers: Novavax coronavirus vaccine enters late stage trials in UK

Christian Fernsby |
Novavax has announced it is starting its Phase 3 trial of an experimental coronavirus vaccine in the UK.

Article continues below



Topics: NOVAVAX   

Up to 10,000 volunteers aged between 18 and 84 will be enrolled for the study, which is set to take place over the next four to six weeks and marks the final step of the regulatory approvals process.

Half of the volunteers will receive two shots of NVX-CoV2373 with Matrix-M, Novavax's adjuvant, which is meant to strengthen the vaccine. The other participants will be given a placebo.


What to read next

Staples and United Way to create over 1,000 youth literacy kits
Ford to produce respirators, masks, scaling up gowns, testing collection kits
Using cloud solutions to increase charitable donations by 40%